back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-20 14:04 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,200
+40,000 vol $6.03 each |
115,000 | |
| Filed 2023-06-20 13:59 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2022-07-22 14:43 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
575 | ||
| Filed 2022-07-06 12:27 Tx date 2022-07-06 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |
| Filed 2022-01-21 14:56 Tx date 2022-01-20 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$423,500
+50,000 vol $8.47 each |
75,000 | |
| Filed 2021-03-31 14:00 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$106,000
+25,000 vol $4.24 each |
25,000 | |
| Filed 2021-03-31 13:59 Tx date 2021-03-29 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
172,391 | |
| Filed 2018-03-21 Tx date 2018-03-19 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$14,000
+100,000 vol $0.14 each |
100,000 | |
| Filed 2018-03-21 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-08 Tx date 2018-03-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
| Filed 2018-03-08 Tx date 2016-05-09 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+500,000 vol $0.255 each |
||
| Filed 2018-03-08 Tx date 2016-05-09 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+500,000 vol $0.255 each |
||
| Filed 2018-03-08 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-08 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-08 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-08 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-08-22 Tx date 2017-08-21 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$11,582
+72,391 vol $0.16 each |
72,391 | |
| Filed 2017-08-22 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-27 Tx date 2016-05-09 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+500,000 vol $0.255 each |
500,000 | |
| Filed 2016-06-20 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-05-10 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|